Somaxon’s Silenor Could Launch In Early ’09 Pending Partnering Discussions
This article was originally published in The Pink Sheet Daily
Executive Summary
Somaxon submits an NDA for the insomnia medication, setting it up for potential FDA approval in December, firm tells "The Pink Sheet" DAILY.